Filtros : "FORP-803" "BARBOSA JUNIOR, FERNANDO" "Alemanha" Limpar

Filtros



Refine with date range


  • Source: Journal of Trace Elements in Medicine and Biology. Unidades: FORP, FMRP, FCFRP

    Subjects: PLASMA (AMOSTRA;ESTUDO), CHUMBO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      REZENDE, Vania B. et al. Should we measure serum or plasma lead concentrations?. Journal of Trace Elements in Medicine and Biology, v. 24, n. 3, p. 147-151, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.jtemb.2010.01.008. Acesso em: 05 ago. 2024.
    • APA

      Rezende, V. B., Amaral, J. H., Gerlach, R. F., Barbosa Júnior, F., & Tanus-Santos, J. E. (2010). Should we measure serum or plasma lead concentrations? Journal of Trace Elements in Medicine and Biology, 24( 3), 147-151. doi:10.1016/j.jtemb.2010.01.008
    • NLM

      Rezende VB, Amaral JH, Gerlach RF, Barbosa Júnior F, Tanus-Santos JE. Should we measure serum or plasma lead concentrations? [Internet]. Journal of Trace Elements in Medicine and Biology. 2010 ; 24( 3): 147-151.[citado 2024 ago. 05 ] Available from: https://doi.org/10.1016/j.jtemb.2010.01.008
    • Vancouver

      Rezende VB, Amaral JH, Gerlach RF, Barbosa Júnior F, Tanus-Santos JE. Should we measure serum or plasma lead concentrations? [Internet]. Journal of Trace Elements in Medicine and Biology. 2010 ; 24( 3): 147-151.[citado 2024 ago. 05 ] Available from: https://doi.org/10.1016/j.jtemb.2010.01.008
  • Source: Archives of Toxicology. Unidades: FORP, FCFRP, FMRP

    Subjects: HIPERTENSÃO, CHUMBO, DOENÇAS CARDIOVASCULARES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RIZZI, Elen et al. Evidence of early involvement of matrix metalloproteinase-2 in lead-induced hypertension. Archives of Toxicology, v. 83, n. 5, p. 439-449, 2009Tradução . . Disponível em: https://doi.org/10.1007/s00204-008-0363-1. Acesso em: 05 ago. 2024.
    • APA

      Rizzi, E., Castro, M. M., Fernandes, K., Barbosa Júnior, F., Arisi, G. M., Garcia-Cairasco, N., et al. (2009). Evidence of early involvement of matrix metalloproteinase-2 in lead-induced hypertension. Archives of Toxicology, 83( 5), 439-449. doi:10.1007/s00204-008-0363-1
    • NLM

      Rizzi E, Castro MM, Fernandes K, Barbosa Júnior F, Arisi GM, Garcia-Cairasco N, Bendhack LM, Tanus-Santos JE, Gerlach RF. Evidence of early involvement of matrix metalloproteinase-2 in lead-induced hypertension [Internet]. Archives of Toxicology. 2009 ; 83( 5): 439-449.[citado 2024 ago. 05 ] Available from: https://doi.org/10.1007/s00204-008-0363-1
    • Vancouver

      Rizzi E, Castro MM, Fernandes K, Barbosa Júnior F, Arisi GM, Garcia-Cairasco N, Bendhack LM, Tanus-Santos JE, Gerlach RF. Evidence of early involvement of matrix metalloproteinase-2 in lead-induced hypertension [Internet]. Archives of Toxicology. 2009 ; 83( 5): 439-449.[citado 2024 ago. 05 ] Available from: https://doi.org/10.1007/s00204-008-0363-1
  • Source: Archives of Toxicology. Unidades: FCFRP, FOB, CENA, FORP, FMRP

    Subjects: BIOMARCADORES, CHUMBO (CONTAMINAÇÃO), SALIVA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BARBOSA JÚNIOR, Fernando et al. Evaluation of the use of salivary lead levels as a surrogate of blood lead or plasma lead levels in lead exposed subjects. Archives of Toxicology, v. 80, n. 10, p. 633-637, 2006Tradução . . Disponível em: https://doi.org/10.1007/s00204-006-0096-y. Acesso em: 05 ago. 2024.
    • APA

      Barbosa Júnior, F., Rodrigues, M. H. C., Buzalaf, M. A. R., Krug, F. J., Gerlach, R. F., & Tanus-Santos, J. E. (2006). Evaluation of the use of salivary lead levels as a surrogate of blood lead or plasma lead levels in lead exposed subjects. Archives of Toxicology, 80( 10), 633-637. doi:10.1007/s00204-006-0096-y
    • NLM

      Barbosa Júnior F, Rodrigues MHC, Buzalaf MAR, Krug FJ, Gerlach RF, Tanus-Santos JE. Evaluation of the use of salivary lead levels as a surrogate of blood lead or plasma lead levels in lead exposed subjects [Internet]. Archives of Toxicology. 2006 ; 80( 10): 633-637.[citado 2024 ago. 05 ] Available from: https://doi.org/10.1007/s00204-006-0096-y
    • Vancouver

      Barbosa Júnior F, Rodrigues MHC, Buzalaf MAR, Krug FJ, Gerlach RF, Tanus-Santos JE. Evaluation of the use of salivary lead levels as a surrogate of blood lead or plasma lead levels in lead exposed subjects [Internet]. Archives of Toxicology. 2006 ; 80( 10): 633-637.[citado 2024 ago. 05 ] Available from: https://doi.org/10.1007/s00204-006-0096-y
  • Source: Archives of Toxicology. Unidades: FCFRP, FORP, FMRP

    Subjects: ÓXIDO NÍTRICO, DOENÇAS CARDIOVASCULARES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BARBOSA JÚNIOR, Fernando et al. Clinical evidence for lead-induced inhibition of nitric oxide formation. Archives of Toxicology, v. 80, n. 12, p. 811-816, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.toxlet.2006.06.330. Acesso em: 05 ago. 2024.
    • APA

      Barbosa Júnior, F., Sertorio, J. T. C., Gerlach, R. F., & Tanus-Santos, J. E. (2006). Clinical evidence for lead-induced inhibition of nitric oxide formation. Archives of Toxicology, 80( 12), 811-816. doi:10.1016/j.toxlet.2006.06.330
    • NLM

      Barbosa Júnior F, Sertorio JTC, Gerlach RF, Tanus-Santos JE. Clinical evidence for lead-induced inhibition of nitric oxide formation [Internet]. Archives of Toxicology. 2006 ; 80( 12): 811-816.[citado 2024 ago. 05 ] Available from: https://doi.org/10.1016/j.toxlet.2006.06.330
    • Vancouver

      Barbosa Júnior F, Sertorio JTC, Gerlach RF, Tanus-Santos JE. Clinical evidence for lead-induced inhibition of nitric oxide formation [Internet]. Archives of Toxicology. 2006 ; 80( 12): 811-816.[citado 2024 ago. 05 ] Available from: https://doi.org/10.1016/j.toxlet.2006.06.330
  • Source: Archives of Toxicology. Unidades: FCFRP, FORP, FMRP

    Subjects: POLIMORFISMO, ÁCIDOS CARBOXÍLICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MONTENEGRO, Marcelo et al. A polymorphism in the delta-aminolevulinic acid dehydratase gene modifies plasma/whole blood lead ratio. Archives of Toxicology, v. 80, n. 7, p. 394-398, 2006Tradução . . Disponível em: https://doi.org/10.1007/s00204-005-0056-y. Acesso em: 05 ago. 2024.
    • APA

      Montenegro, M., Barbosa Júnior, F., Sandrim, V. C., Gerlach, R. F., & Tanus-Santos, J. E. (2006). A polymorphism in the delta-aminolevulinic acid dehydratase gene modifies plasma/whole blood lead ratio. Archives of Toxicology, 80( 7), 394-398. doi:10.1007/s00204-005-0056-y
    • NLM

      Montenegro M, Barbosa Júnior F, Sandrim VC, Gerlach RF, Tanus-Santos JE. A polymorphism in the delta-aminolevulinic acid dehydratase gene modifies plasma/whole blood lead ratio [Internet]. Archives of Toxicology. 2006 ; 80( 7): 394-398.[citado 2024 ago. 05 ] Available from: https://doi.org/10.1007/s00204-005-0056-y
    • Vancouver

      Montenegro M, Barbosa Júnior F, Sandrim VC, Gerlach RF, Tanus-Santos JE. A polymorphism in the delta-aminolevulinic acid dehydratase gene modifies plasma/whole blood lead ratio [Internet]. Archives of Toxicology. 2006 ; 80( 7): 394-398.[citado 2024 ago. 05 ] Available from: https://doi.org/10.1007/s00204-005-0056-y

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024